The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Shai Gilgeous-Alexander scored 34 points and then took over the city of Boston with the help of his sneaker sponsor. After ...

The great Gucci reset is here. On Wednesday, the Italian fashion house named Demna, the mononymic designer who transformed ...

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor ...

Korean Air rebrands for the first time in 40 years with a simplified new look by Lippincott designed to reach global ...

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, ...

Genentech has been working on AI-powered technologies for drug discovery and development, coming up with a proprietary set of algorithms and other computational tools for new drug design.

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...